PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-01-13

Date Title Company
13-Jan-2025 TheraVac Biologics Partners With Perceiv AI to Optimize Clinical Trials Using Advanced AI and Prognostic Biomarkers Newswire
13-Jan-2025 Integrated DNA Technologies Names Ajay Gannerkote as New President to Lead Bold Era of Innovation and Growth Integrated DNA Technologies
13-Jan-2025 Proscia’s Growth More Than Doubles As Customers Adopt Enterprise Pathology Proscia
13-Jan-2025 NeilMed Announces Free Sinus Rinse Saline Product Donations to Provide Immediate Relief for First Responders Fighting Wildfires in Los Angeles AccessWire
13-Jan-2025 OncoZenge AB has entered into a non-binding agreement with the intention to partner with Molteni Farmaceutici for commercialization of BupiZenge™ in Europe OncoZenge AB
13-Jan-2025 Caidya Announces $165 Million Strategic Growth Investment from Rubicon Founders Caidya
13-Jan-2025 TheraVac Biologics Partners With Perceiv AI to Optimize Clinical Trials Using Advanced AI and Prognostic Biomarkers AccessWire
13-Jan-2025 Permanent Makeup Tattoo Removal Now Available at Skin & Laser Dermatology Center AccessWire
13-Jan-2025 Advanced Bipolar Direct Energy Devices Market Acumen Research and Consulting
13-Jan-2025 Ariceum Therapeutics and ITM Enter Supply Agreement for Therapeutic Medical Radioisotope Actinium-225 Ariceum Therapeutics
13-Jan-2025 Rappta Therapeutics enters into a global license agreement with SpringWorks Therapeutics for a pre-clinical first-in-class molecular glue targeting PP2A Rappta Therapeutics
13-Jan-2025 Medicines Discovery Catapult Strengthens Senior Leadership Team with Two Executive Appointments Medicines Discovery Catapult
13-Jan-2025 AbbVie’s SKYRIZI® (risankizumab) Accepted by the Scottish Medicines Consortium for Adults with Moderately to Severely Active Ulcerative Colitis AbbVie
13-Jan-2025 Chromatin Bioscience’s synthetic promoter supports EsoBiotec’s ESO-T01 CAR-T therapy as it enters the clinic Chromatin Bioscience
13-Jan-2025 Heidelberg Pharma Progresses into Cohort 7 in a Phase I/IIa Study with BCMA ATAC Candidate HDP-101 Targeting Multiple Myeloma Heidelberg Pharma
13-Jan-2025 Outrun Therapeutics expands leadership team with appointment of Matthew Fyfe as Chief Scientific Officer Outrun Therapeutics
13-Jan-2025 CNX Therapeutics expands European CNS portfolio with licensing agreement for Sumatriptan Alginate Film CNX Therapeutics
13-Jan-2025 Accident Medical Group Achieves Milestone With 1,000 Providers in Florida, Setting a New Standard for Personal Injury Care AccessWire
13-Jan-2025 Ainos Unveils AI Nose for Robotics: Invites Global Robotics Companies to Join Forces in Shaping the Future of Smell-Enabled Robots AccessWire
13-Jan-2025 Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma Sanofi